Log In
Print this Print this

Vantera Clinical Analyzer

  Manage Alerts
Collapse Summary General Information
Company Laboratory Corp. of America Holdings
DescriptionClinical diagnostic platform combining signal processing algorithms and nuclear magnetic resonance to identify and quantify concentrations of lipoproteins and, potentially, small molecule metabolites
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentApproved
Standard IndicationCardiovascular, Diagnostic
Indication DetailsFor use with the NMR LipProfile test to measure lipoprotein particles to asses the risk of developing cardiovascular disease. C
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today